Janus kinase (JAK) inhibitors

Janus kinase (JAK) inhibitors are medications that block specific enzymes called JAKs, which play a key role in the body's immune response. By inhibiting these enzymes, JAK inhibitors help reduce inflammation and immune activity that contribute to conditions like rheumatoid arthritis, psoriasis, and certain blood disorders. They work by interfering with the signaling pathways inside cells that trigger inflammation, offering targeted treatment options for autoimmune diseases. These drugs are typically taken orally and are prescribed under medical supervision to manage symptoms and improve quality of life.